tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Smart Growth
New
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsTrendingPortfolio
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
TipRanks Momentum Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Class Actions
Class Actions
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

QNCX Stock Latest News

Quince Therapeutics presents data from prior Phase 3 ATTeST clinical trial
The FlyQuince Therapeutics presents data from prior Phase 3 ATTeST clinical trial
9d ago
QNCX
Quince Therapeutics presents safety data from ATTeST trial at CNS meeting
PremiumThe Fly
Quince Therapeutics presents safety data from ATTeST trial at CNS meeting
10d ago
QNCX
Quince Therapeutics initiated with a Buy at Maxim
PremiumThe Fly
Quince Therapeutics initiated with a Buy at Maxim
14d ago
QNCX
Quince Therapeutics initiated with a Buy at Rodman & Renshaw
PremiumThe Fly
Quince Therapeutics initiated with a Buy at Rodman & Renshaw
23d ago
QNCX
Quince Therapeutics initiated with a Buy at EF Hutton
PremiumThe Fly
Quince Therapeutics initiated with a Buy at EF Hutton
1M ago
QNCX
Quince Therapeutics announces Phase 3 ATTeST trial for A-T evaluated in Lancet
PremiumThe FlyQuince Therapeutics announces Phase 3 ATTeST trial for A-T evaluated in Lancet
3M ago
QNCX
Quince Therapeutics announces first patient dosed in Phase 3 trial of EryDex
Premium
The Fly
Quince Therapeutics announces first patient dosed in Phase 3 trial of EryDex
5M ago
QNCX
Quince Therapeutics announces fast track designation for EryDex System
Premium
The Fly
Quince Therapeutics announces fast track designation for EryDex System
6M ago
QNCX
Quince Therapeutics Appoints Rajiv Patni to Board of Directors
PremiumCompany Announcements
Quince Therapeutics Appoints Rajiv Patni to Board of Directors
9M ago
8K
QNCX
Quince Therapeutics Executive Compensation and Stock Option Update
PremiumCompany Announcements
Quince Therapeutics Executive Compensation and Stock Option Update
10M ago
8K
QNCX
Quince Therapeutics says FDA lifts partical clinical hold on EryDel’s EryDex IND
PremiumThe Fly
Quince Therapeutics says FDA lifts partical clinical hold on EryDel’s EryDex IND
1y ago
QNCX
Quince to acquire EryDel in up-front stock deal + potential milestone
PremiumThe Fly
Quince to acquire EryDel in up-front stock deal + potential milestone
1y ago
QNCX
Quince to acquire EryDel and Ataxia-Telangiectasia
PremiumThe FlyQuince to acquire EryDel and Ataxia-Telangiectasia
1y ago
QNCX
Echo Lake increases offer to acquire Quince Therapeutics to $1.80 per share
Premium
The Fly
Echo Lake increases offer to acquire Quince Therapeutics to $1.80 per share
1y ago
QNCX
Quince rejects Echo Lake Capital’s $1.60 per share acquisition offer
Premium
The Fly
Quince rejects Echo Lake Capital’s $1.60 per share acquisition offer
2y ago
QNCX
Quince Therapeutics engages MTS Heath Partners to review strategic alternatives
PremiumThe Fly
Quince Therapeutics engages MTS Heath Partners to review strategic alternatives
2y ago
QNCX
Quince Therapeutics confirms unsolicited acquisition offer from Echo Lake
PremiumThe Fly
Quince Therapeutics confirms unsolicited acquisition offer from Echo Lake
2y ago
QNCX
QNCX Soars on $1.60 Per Share Bid from Echo Lake
PremiumMarket News
QNCX Soars on $1.60 Per Share Bid from Echo Lake
2y ago
QNCX
Echo Lake offers to acquire Quince Therapeutics for $1.60 per share in cash
PremiumThe Fly
Echo Lake offers to acquire Quince Therapeutics for $1.60 per share in cash
2y ago
QNCX

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >